news flash·2025-06-04 13:45Group 1 - The Ministry of Industry and Information Technology is promoting the development of the artificial intelligence industry and empowering new industrialization, focusing on the layout of general large models and industry-specific large models, emphasizing hardware and software adaptation, and accelerating the establishment of high-quality industry data sets to enhance the intelligence level of key product equipment [1] - The Hong Kong Securities and Futures Commission is considering introducing virtual asset derivatives trading for professional investors, encouraging local and international companies to explore innovations and applications of virtual asset technology [1] - The National Energy Administration is organizing the first batch of pilot work for the construction of a new power system, coordinating regional stock and incremental data center green electricity demand and new energy resource conditions, and collaboratively planning the layout of computing power and electricity projects [1] Group 2 - The Ministry of Finance and the Ministry of Housing and Urban-Rural Development are conducting the 2025 annual evaluation for central financial support for urban renewal actions, planning to support 20 cities including Beijing and Tianjin in implementing urban renewal actions [1] - Kingsoft Office continues to appoint Lei Jun as the honorary chairman of the company [1] - Sinovac Biotech's controlling shareholder, Koyi Medicine, plans to reduce its holdings by no more than 3% of the company's shares [1] - Zhongheng Design has reported that the revenue from its "low-altitude economy" and "commercial aerospace" related project designs is relatively small [1] - Lehui International has indicated that its fresh beer business accounts for a small proportion and is still in a loss stage [1] - A portion of the company's directors and supervisors at Aoheng Co., Ltd. reduced their holdings by 153,000 shares during the period of abnormal stock trading according to the reduction plan [1] - Wantai Biological's application for marketing authorization of its nine-valent HPV vaccine has been approved [1]